These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16919501)

  • 1. Cooperation to amplify gene-dosage-imbalance effects.
    de la Luna S; Estivill X
    Trends Mol Med; 2006 Oct; 12(10):451-4. PubMed ID: 16919501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trisomy of the Dscr1 gene suppresses early progression of pancreatic intraepithelial neoplasia driven by oncogenic Kras.
    Lee JC; Shin J; Baek KH
    Biochem Biophys Res Commun; 2013 Oct; 440(1):50-5. PubMed ID: 24041692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21.
    Arron JR; Winslow MM; Polleri A; Chang CP; Wu H; Gao X; Neilson JR; Chen L; Heit JJ; Kim SK; Yamasaki N; Miyakawa T; Francke U; Graef IA; Crabtree GR
    Nature; 2006 Jun; 441(7093):595-600. PubMed ID: 16554754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased dosage of DYRK1A and DSCR1 delays neuronal differentiation in neocortical progenitor cells.
    Kurabayashi N; Sanada K
    Genes Dev; 2013 Dec; 27(24):2708-21. PubMed ID: 24352425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease.
    Ryoo SR; Cho HJ; Lee HW; Jeong HK; Radnaabazar C; Kim YS; Kim MJ; Son MY; Seo H; Chung SH; Song WJ
    J Neurochem; 2008 Mar; 104(5):1333-44. PubMed ID: 18005339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular Mechanism Underlying Abnormal Differentiation of Neural Progenitor Cells in the Developing Down Syndrome Brain].
    Kurabayashi N; Sanada K
    Yakugaku Zasshi; 2017; 137(7):795-800. PubMed ID: 28674289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Down Syndrome Critical Region 1 expression by Nuclear Factor of Activated T cells in megakaryocytes.
    Kyttälä S; Habermann I; Minami T; Ehninger G; Kiani A
    Br J Haematol; 2009 Feb; 144(3):395-408. PubMed ID: 19036088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of RCAN1 protein activity by Dyrk1A protein-mediated phosphorylation.
    Jung MS; Park JH; Ryu YS; Choi SH; Yoon SH; Kwen MY; Oh JY; Song WJ; Chung SH
    J Biol Chem; 2011 Nov; 286(46):40401-12. PubMed ID: 21965663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-specificity tyrosine-phosphorylated and regulated kinase 1A (DYRK1A) interacts with the phytanoyl-CoA alpha-hydroxylase associated protein 1 (PAHX-AP1), a brain specific protein.
    Bescond M; Rahmani Z
    Int J Biochem Cell Biol; 2005 Apr; 37(4):775-83. PubMed ID: 15694837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mental retardation and associated neurological dysfunctions in Down syndrome: a consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways.
    Rachidi M; Lopes C
    Eur J Paediatr Neurol; 2008 May; 12(3):168-82. PubMed ID: 17933568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down syndrome offers fresh clues to angiogenesis.
    Rowan K
    J Natl Cancer Inst; 2009 Sep; 101(17):1170-1. PubMed ID: 19706624
    [No Abstract]   [Full Text] [Related]  

  • 12. Engineering DYRK1A overdosage yields Down syndrome-characteristic cortical splicing aberrations.
    Toiber D; Azkona G; Ben-Ari S; Torán N; Soreq H; Dierssen M
    Neurobiol Dis; 2010 Oct; 40(1):348-59. PubMed ID: 20600907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A patient with Down syndrome with a de novo derivative chromosome 21.
    Cetin Z; Yakut S; Mihci E; Manguoglu AE; Berker S; Keser I; Luleci G
    Gene; 2012 Oct; 507(2):159-64. PubMed ID: 22827956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between beta-amyloid production and tau phosphorylation in Alzheimer disease.
    Kimura R; Kamino K; Yamamoto M; Nuripa A; Kida T; Kazui H; Hashimoto R; Tanaka T; Kudo T; Yamagata H; Tabara Y; Miki T; Akatsu H; Kosaka K; Funakoshi E; Nishitomi K; Sakaguchi G; Kato A; Hattori H; Uema T; Takeda M
    Hum Mol Genet; 2007 Jan; 16(1):15-23. PubMed ID: 17135279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of DYRK1A activity inhibition on development of neuronal progenitors isolated from Ts65Dn mice.
    Mazur-Kolecka B; Golabek A; Kida E; Rabe A; Hwang YW; Adayev T; Wegiel J; Flory M; Kaczmarski W; Marchi E; Frackowiak J
    J Neurosci Res; 2012 May; 90(5):999-1010. PubMed ID: 22252917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spatio-temporal and subcellular expression of the candidate Down syndrome gene Mnb/Dyrk1A in the developing mouse brain suggests distinct sequential roles in neuronal development.
    Hämmerle B; Elizalde C; Tejedor FJ
    Eur J Neurosci; 2008 Mar; 27(5):1061-74. PubMed ID: 18364031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased dosage of DYRK1A and brain volumetric alterations in a YAC model of partial trisomy 21.
    Sebrié C; Chabert C; Ledru A; Guedj F; Po C; Smith DJ; Rubin E; Rivals I; Beloeil JC; Gillet B; Delabar JM
    Anat Rec (Hoboken); 2008 Mar; 291(3):254-62. PubMed ID: 18231969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A genome-wide Drosophila RNAi screen identifies DYRK-family kinases as regulators of NFAT.
    Gwack Y; Sharma S; Nardone J; Tanasa B; Iuga A; Srikanth S; Okamura H; Bolton D; Feske S; Hogan PG; Rao A
    Nature; 2006 Jun; 441(7093):646-50. PubMed ID: 16511445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of DYRK1A inhibits choline acetyltransferase induction by oleic acid in cellular models of Down syndrome.
    Hijazi M; Fillat C; Medina JM; Velasco A
    Exp Neurol; 2013 Jan; 239():229-34. PubMed ID: 23124096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of DSCR1 to disomy in the trisomy 16 mouse model of Down syndrome does not correct cardiac or craniofacial development anomalies.
    Lange AW; Rothermel BA; Yutzey KE
    Dev Dyn; 2005 Jul; 233(3):954-63. PubMed ID: 15906378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.